Specific cytotoxic T lymphocyte responses against Melan-A/Mart1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: The role of cellular immunity in the etiopathogenesis of Vitiligo

Journal of Investigative Dermatology

Volumn 117, Issue 2, 2001, Pages 326-332

  Palermo, Belinda ^a   Campanelli, Rita ^a   Garbelli, Silvia ^a   Mantovani, Stefania ^a   Lantelme, Erica ^a   Brazzelli, Valeria ^b   Ardigó, Marco ^b   Borroni, Giovanni ^b   Martinetti, Miriam ^c   Badulli, Carla ^c   Necker, Antje ^d   Giachino, Claudia ^a,e  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d Immunotech   (France)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

Cytotoxic T lymphocytes; Human; Melanocyte differentiation antigen; Vitiligo

Indexed keywords

CD8 ANTIGEN; GLYCOPROTEIN GP 100; MELAN A; MONOPHENOL MONOOXYGENASE; TETRAMER;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DEPIGMENTATION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MELANOCYTE; PATHOGENESIS; PRIORITY JOURNAL; VITILIGO;

EID: 0035721929     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01408.x     Document Type: Article

References (51)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Celis E: Synthetic antigenic peptides as a new strategy for immunotherapy of cancer
3. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo
4. An immunohistological study of cutaneous lymphocytes in vitiligo
5. Antibodies to melanocytes in vitiligo
6. Cancer tumor antigens
7. Immune mechanisms in vitiligo
8. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
9. Cytolytic antibodies to melanocytes in vitiligo
10. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells
11. Shift in the phenotype of Melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
12. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
13. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo
14. A fail-safe mechanism for maintaining self-tolerance
15. New and emerging therapies for vitiligo
16. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules
17. The use of HLA A2.1/p 53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
18. Differential expression of MART-1 in primary and metastatic melanoma lesions
19. T cell tolerance by clonal elimination in the thymus
20. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay
21. High- and low-potency ligands with similar affinities for the TCR. The importance of kinetics in TCR signaling
22. + thymocytes
23. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance
24. Thymic selection by a single MHC/ peptide ligand: Autoreactive T cells are low-affinity cells
25. Low avidity recognition of self-antigen by T cells permits escape from central tolerance
26. Empty MHC class I molecules come out in the cold
27. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1 (27- 35)
28. Peripheral T-cell activation in non-segmental vitiligo
29. Non PUVA nonsurgical therapies for vitiligo
30. Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions
31. Melanoma-associated hypopigmentation: Where are the antibodies?
32. The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions
33. Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity
34. Hypomelanoses and Hypermelanoses
35. Antibodies to normal human melanocytes in vitiligo
36. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
37. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy
38. HLA-DQB1 and DQA1 typing by PCR amplification with sequence specific primers PCR-SSP in two hours
39. Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients
40. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues
41. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
42. PUVA-therapy and association of phenylalanine and UVA-therapy in vitiligo. A multicenter-study of 81 observations
43. The role of tyrosinase in autoimmune vitiligo
44. T-cell apoptosis detected in situ during positive and negative selection in the thymus
45. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
46. An antigen-targeted approach to adoptive transfer therapy of cancer
47. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376
48. T cell defined tumor antigens
49. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
50. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope
51. A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex